Thomas Lavin
Partner
New Science VenturesNew York City, New York, United States
45 investmentsThomas Lavin is a Partner at New Science Ventures based in New York City, New York, United States. Thomas Lavin has backed 45 companies, including Paradigm Diagnostics, Vuv Analytics and Kateeva. Investment focus areas include Health Care, Telecommunications and Regenerative Medicine.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Health Care
Telecommunications
Regenerative Medicine
Genetics
Autonomous Vehicles
Cybersecurity
Wellness
Android
Satellite Imagery
Life Science
Information Technology (IT)
Internet of Things (IoT)
Software
Graphene
Manufacturing
Biotechnology
Medical Devices
Genomics
Disruptive technology
Hardware
Marketing
Logistics
Nanotechnology
Medical
SaaS
Battery
Information Technology
B2B
Therapeutics
Media and Entertainment
Air Transportation
Portfolio Companies (45)
| 1 | Paradigm Diagnostics |
| 2 | Vuv Analytics |
| 3 | Kateeva |
| 4 | Vaultive |
| 5 | Celleration |
| 6 | Oxyrane UK |
| 7 | Ikonisys |
| 8 | NorthSea Therapeutics |
| 9 | ProterixBio |
| 10 | MetLife Real Estate |
| 11 | Citibank |
| 12 | Lightwire |
Showing 1–12 of 45
Page 1 of 4
Access Full Contact Information
Get Thomas Lavin's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
3-day free trial, cancel anytime
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.